Skip to main content
. 2016 Aug 2;8(21):34205–34222. doi: 10.18632/oncotarget.11009

Figure 4. Bladder cancer CTCs are characterized by TGFβ pathway activation and loss of adherens junction gene expression.

Figure 4

Whole genome mRNA expression profiling was performed on primary tumors, CTCs, and metastases. (A) Heatmap of the top differentially expressed genes (FDR < 0.05, p < 0.001) between CTCs and others cancer-involved tissues. (B) Expression of TGFβ pathway targets in the KEGG pathway (p < 0.05). (C) Expression of adherens junction genes in KEGG pathway (p < 0.05).